Safety, efficacy, and duration of effect of a new Botulinum Neurotoxin Type A preparation free of complexing proteins

被引：0

|

作者：

Wohlfarth, K

Mueller, C

机构：

来源：

MOVEMENT DISORDERS | 2005年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P35

引用

收藏

页码：S11 / S11

页数：1

相关论文

共 50 条

[21] Efficacy and Safety of NT 201 (Neurotoxin Free from Complexing Proteins) in Cervical Dystonia
Comella, Cynthia
Jankovic, Joseph
Truong, Daniel
Hanschmann, Angelika
Grafe, Susanne
NEUROLOGY, 2009, 72 (11) : A345 - A345
[22] The complexing proteins of botulinum neurotoxin type A bind to neuronal and nonneuronal cells
Wang, Lei
Singh, Bal Ram
Sun, Yi
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB29 - AB29
[23] Overall clinical efficacy and overall tolerability of NT 201; botulinum neurotoxin free front complexing proteins)
Benecke, R.
Grafe, S.
Sassin, I.
Comes, G.
MOVEMENT DISORDERS, 2009, 24 : S84 - S84
[24] Safety and Efficacy of Repeated NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) Injections of Patients with Cervical Dystonia: A First Long-Term Safety Analysis
Grafe, Susanne
Hanschmann, Angelika
NEUROLOGY, 2010, 74 (09) : A88 - A88
[25] Safety and efficacy of repeated NT 201 (botulinum neurotoxin type a free from complexing proteins) injections of patients with cervical dystonia: A first long-term safety analysis
Hanschmann, A.
Grafe, S.
MOVEMENT DISORDERS, 2010, 25 (07) : S237 - S237
[26] EFFICACY AND SAFETY OF TREATMENT WITH INCOBOTULINUM TOXIN A (BOTULINUM NEUROTOXIN TYPE A FREE FROM COMPLEXING PROTEINS; NT 201) IN POST-STROKE UPPER LIMB SPASTICITY
Kanovsky, Petr
Slawek, Jaroslaw
Denes, Zoltan
Platz, Thomas
Comes, Georg
Grafe, Susanne
Pulte, Irena
JOURNAL OF REHABILITATION MEDICINE, 2011, 43 (06) : 486 - 492
[27] Efficacy and safety of a new botulinunt toxin type A free of complexing proteins in treatment of blepharospasm
Roggenkämper, P
MOVEMENT DISORDERS, 2004, 19 : S84 - S85
[28] Clinical Efficacy in Focal Dystonia and Overall Tolerability of NT 201 (Botulinum Neurotoxin Free from Complexing Proteins)
Grafe, Susanne
Comes, Georg
Sassin, Irena
NEUROLOGY, 2009, 72 (11) : A344 - A344
[29] Is there a role for complexing proteins in pharmaceutical botulinum neurotoxin formulations?
Eisele, Karl-Heinz
Mander, Gerd J.
Taylor, Harold V.
Grein, Swen
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB27 - AB27
[30] A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
Benecke, R
Jost, WH
Kanovsky, P
Ruzicka, E
Comes, G
Grafe, S
NEUROLOGY, 2005, 64 (11) : 1949 - 1951

← 1 2 3 4 5 →